Invention Grant
- Patent Title: 4′-substituted nucleoside reverse transcriptase inhibitors
-
Application No.: US14669398Application Date: 2015-03-26
-
Publication No.: US09777035B2Publication Date: 2017-10-03
- Inventor: Vinay M. Girijavallabhan , David B. Olsen , Zhibo Zhang , Jianmin Fu , Bing-Yu Tang
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: MERCK SHARP & DOHME CORP.
- Current Assignee: MERCK SHARP & DOHME CORP.
- Current Assignee Address: US NJ Rahway
- Agent Carol S. Quagliato; Catherine D. Fitch
- Priority: WOPCT/CN2014/074294 20140328
- Main IPC: A61K31/7064
- IPC: A61K31/7064 ; A61K45/06 ; C07H19/12 ; C07H19/14 ; C07H19/06 ; C07D487/04
Abstract:
The present invention is directed to 4′-substituted nucleoside derivatives of Formula I and their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS and/or ARC.
Public/Granted literature
- US20150274767A1 4'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS Public/Granted day:2015-10-01
Information query
IPC分类:
